Adenovirus-Mediated Gene Therapy of Osteoblasts In Vitro and In Vivo
- 1 August 1999
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 14 (8) , 1290-1301
Abstract
Modulation of biological pathways governing osteogenesis may accelerate osseous regeneration and reduce the incidence of complications associated with fracture healing. Transforming growth factor β1 (TGF-β1) is a potent growth factor implicated in the regulation of osteogenesis and fracture repair. The use of recombinant proteins, however, has significant disadvantages and has limited the clinical utility of these molecules. Targeted gene therapy using adenovirus vectors is a technique that may circumvent difficulties associated with growth factor delivery. In this study, we investigate the efficacy of replication-deficient adenoviruses containing the human TGF-β1 and the bacterial lacZ genes in transfecting osteoblasts in vitro and osseous tissues in vivo. We demonstrate that adenovirus-mediated gene therapy efficiently transfects osteoblasts in vitro with the TGF-β1 virus causing a marked up-regulation in TGF-β1 mRNA expression even 7 days after transfection. Increased TGF-β1 mRNA expression was efficiently translated into protein production and resulted in approximately a 46-fold increase in TGF-β1 synthesis as compared with control cells (vehicle- or B-galactosidase–transfected). Moreover, virally produced TGF-β1 was functionally active and regulated the expression of collagen IαI (5-fold increase) and the vascular endothelial growth factor (2.5-fold increase). Using an adenovirus vector encoding the Escherichia coli LacZ gene, we demonstrated that adenovirus-mediated gene transfer efficiently transfects osteoblasts and osteocytes in vivo and that transfection can be performed by a simple percutaneous injection. Finally, we show that delivery of the hTGF-β1 gene to osseous tissues in vivo results in significant changes in the epiphyseal plate primarily as a result of increased thickness of the provisional calcification zone.Keywords
This publication has 57 references indexed in Scilit:
- TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4The EMBO Journal, 1997
- Dominant-Negative SMAD-3 Interferes with Transcriptional Activation by Multiple AgonistsBiochemical and Biophysical Research Communications, 1997
- TGFβ Signaling: Receptors, Transducers, and Mad ProteinsCell, 1996
- Characterization of transforming growth factor‐β growth regulatory effects and receptors on bovine mammary cellsJournal of Cellular Physiology, 1995
- Mechanism of activation of the TGF-β receptorNature, 1994
- Transforming growth factor-β enhances fracture healing in rabbit tibiaeActa Orthopaedica, 1993
- Transforming growth factor-β-induced gene expression of monocyte chemoattractant JE in mouse osteoblastic cells, MC3T3-E1Biochemical and Biophysical Research Communications, 1991
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- Transforming growth factor-β-induced mitogenesis of human bone cancer cellsBiochemical and Biophysical Research Communications, 1989
- The Role of Periosteal Blood Supply in the Healing of Fractures of the TibiaClinical Orthopaedics and Related Research, 1974